For example, when GAP43, neurogranin, synaptotagmins, Rab3A, and SNAP25 are present in the exosomes of AD patients, this helps detect preclinical AD about 5–7 years prior to symptom onset [56, 57]. This evidence concerns the gene RAB3A and Alzheimer disease.